Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Michele Simon
Grant and Contract Administrator II
Asthma/Airway Disease Rsch Ctr
Full Page
Overview
Research
More
Collaboration
(18)
Fernando Martinez
Mutual work: 2 Proposals﹒3 Grants
Collaboration Details
Stefano Guerra
Mutual work: 3 Grants﹒2 Proposals
Collaboration Details
Wayne Morgan
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Cori Daines
Mutual work: 5 Grants﹒7 Proposals
Collaboration Details
Michael Daines
Mutual work: 4 Grants﹒6 Proposals
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(12)
A Multicentre, Randomised, Double-blind, Parallel Group,Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eos
Active
·
2023
·
$0 / $2.9M
·
External
asthma,
pediatric patients,
clinical trial,
drug treatment
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Study to Assess the Efficacy and Safety of Daily OM-85 Treatment Versus Placebo Given on Top of Standard of Care in Children Aged
Active
·
2023
·
$0 / $814.9K
·
External
clinical trial,
immunotherapy,
pediatric medicine,
respiratory health,
drug efficacy
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous lmmunotherapy with DBV712 250 ?g in 4-7-year-old Children with Peanut Allergy (VITESSE)
Active
·
2023
·
$0 / $397.9K
·
External
immunotherapy,
peanut allergy,
efficacy,
safety,
children
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
Active
·
2023
·
$0 / $292K
·
External
nutrition,
lung function,
muscle strength,
cystic fibrosis,
outcomes
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)
Active
·
2023
·
$0 / $137.8K
·
External
clinical trials,
peanut allergy,
vaccine,
safety,
efficacy
Page 1 of 3
Previous page
Next page
